ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma ; volume:31 ; number:10 ; day:17 ; month:7 ; year:2024 ; pages:7074-7075 ; date:10.2024
Annals of surgical oncology ; 31, Heft 10 (17.7.2024), 7074-7075, 10.2024
- Creator
-
Konishi, Takanori
Takano, Shigetsugu
Ohtsuka, Masayuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-024-15853-1
- URN
-
urn:nbn:de:101:1-2412022133597.330586542379
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Konishi, Takanori
- Takano, Shigetsugu
- Ohtsuka, Masayuki
- SpringerLink (Online service)
Other Objects (12)
ASO Author Reflections: Personalized Breast Cancer Treatment Using Preoperative Partial Breast Irradiation
Resectable pancreatic ductal adenocarcinoma: association between preoperative CT texture features and metastatic nodal involvement
ASO Author Reflections: Preoperative Prediction of Postmastectomy Radiation Therapy After Neoadjuvant Systemic Therapy
Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma
Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma
ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer—Resection Cuts the Deal
ASO Author Reflections: Von Willebrand Factor for Assessment of Portal Hypertension and Perioperative Risk in Resectable HCC
ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
ASO Author Reflections: Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma and Operative Margin Revision
ASO Author Reflections: Accurate Evaluation of Malignant Potential in Pancreatic Ductal Adenocarcinoma Using DUPAN-2 Level
ASO Author Reflections: Surgical Predictors for Survival in Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Molecular biological characterisation of resectable pancreatic ductal adenocarcinoma
ASO Author Reflections: Personalized Breast Cancer Treatment Using Preoperative Partial Breast Irradiation
Resectable pancreatic ductal adenocarcinoma: association between preoperative CT texture features and metastatic nodal involvement
ASO Author Reflections: Preoperative Prediction of Postmastectomy Radiation Therapy After Neoadjuvant Systemic Therapy
Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma
Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma
ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer—Resection Cuts the Deal
ASO Author Reflections: Von Willebrand Factor for Assessment of Portal Hypertension and Perioperative Risk in Resectable HCC
ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
ASO Author Reflections: Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma and Operative Margin Revision
ASO Author Reflections: Accurate Evaluation of Malignant Potential in Pancreatic Ductal Adenocarcinoma Using DUPAN-2 Level
ASO Author Reflections: Surgical Predictors for Survival in Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Molecular biological characterisation of resectable pancreatic ductal adenocarcinoma
ASO Author Reflections: Personalized Breast Cancer Treatment Using Preoperative Partial Breast Irradiation
Resectable pancreatic ductal adenocarcinoma: association between preoperative CT texture features and metastatic nodal involvement
ASO Author Reflections: Preoperative Prediction of Postmastectomy Radiation Therapy After Neoadjuvant Systemic Therapy
Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma
Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma
ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer—Resection Cuts the Deal
ASO Author Reflections: Von Willebrand Factor for Assessment of Portal Hypertension and Perioperative Risk in Resectable HCC
ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
ASO Author Reflections: Isolated Margin Positivity in Localized Pancreatic Ductal Adenocarcinoma and Operative Margin Revision
ASO Author Reflections: Accurate Evaluation of Malignant Potential in Pancreatic Ductal Adenocarcinoma Using DUPAN-2 Level
ASO Author Reflections: Surgical Predictors for Survival in Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma